68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer

被引：13

作者：

Aydin, Funda ^{[1
]}

Akcal, Arzu ^{[2
]}

Unal, Betul ^{[3
]}

Goksu, Sema Sezgin ^{[4
]}

Gungor, Firat ^{[5
]}

机构：

[1] Akdeniz Univ, Dept Nucl Med, Antalya, Turkey

[2] Akdeniz Univ, Dept Plast Reconstruct & Aesthet Surg, Antalya, Turkey

[3] Akdeniz Univ, Dept Pathol, Antalya, Turkey

[4] Akdeniz Univ, Dept Med Oncol, Antalya, Turkey

[5] Emsey Hosp, Dept Nucl Med, Istanbul, Turkey

来源：

CLINICAL NUCLEAR MEDICINE | 2017年 / 42卷 / 05期

关键词：

Ga-68-PSMA PET/CT; dermatofibroma; PSMA; GA-68-LABELED PSMA LIGAND; HBED-CC; PET/CT; EXPRESSION; CARCINOMA; DIAGNOSIS;

D O I：

10.1097/RLU.0000000000001591

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Prostate-specific membrane antigen (PSMA) is a typ. 2 transmembrane protein that is highly expressed in prostate cancer cells. 68Ga-PSMA PET/CT imaging is a modality used to determine the extent of prostate cancer. Various other neoplasias may also express PSMA, which appears as 68Ga-PSMA uptake in PET/CT imaging. A 71-year-old man with prostate cancer underwent 68Ga-PSMA PET/CT imaging for restaging after having an elevated prostate-specific antigen level. Subcutaneous lesions showing focal PSMA uptake were detected, one of which was excised. The histopathologic diagnosis was dermatofibroma. © 2017 Wolters Kluwer Health, Inc. All rights reserved.

引用

页码：358 / 360

页数：3

共 50 条

[31] Incidental Detection of Pleomorphic Sarcoma on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer
Mathew, Boon
Agrawal, Archi
Purandare, Nilendu C.
Ramadwar, Mukta
Menon, Santosh
Bakshi, Ganesh
Joshi, Amit
Puranik, Ameya
Shah, Sneha
Rangarajan, Venkatesh
CLINICAL NUCLEAR MEDICINE, 2020, 45 (02) : E120 - E121
[32] 68Ga-PSMA imaging of metastatic breast cancer
Sathekge, Mike
Modiselle, Moshe
Vorster, Mariza
Mokgoro, Neo
Nyakale, Nozipho
Mokaleng, Brenda
Ebenhan, Thomas
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (09) : 1482 - 1483
[33] Correlations of 68Ga-PSMA PET/CT in the initial staging of prostate cancer patients
Topuz, Ozge Vural
Aksu, Aysegul
Erinc, Sadife Ruya
Tamam, Muge Oner
HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2021, 24 (01): : 60 - 65
[34] Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
Rahbar, Kambiz
Weckesser, Matthias
Huss, Sebastian
Semjonow, Axel
Breyholz, Hans-Joerg
Schrader, Andres J.
Schaefers, Michael
Boegemann, Martin
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (04) : 563 - 567
[35] The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer
Hoffmann, Manuela A.
Wieler, Helmut J.
Baues, Christian
Kuntz, Nicholas J.
Richardsen, Ines
Schreckenberger, Mathias
UROLOGY, 2019, 130 : 1 - 12
[36] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
Tulsyan, Shruti
Das, Chandan J.
Tripathi, Madhavi
Seth, Amlesh
Kumar, Rajeev
Bal, Chandrasekhar
NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
[37] Avid 68Ga-PSMA Uptake in Accessory Submandibular Salivary Gland
Zhang, Wei
Zhang, Li
Zhao, Yanhong
Chen, Yue
CLINICAL NUCLEAR MEDICINE, 2019, 44 (07) : 591 - 593
[38] 68Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?
Lengana, Thabo
Lawal, Ismaheel O.
Boshomane, Tebatso G.
Popoola, Gbenga O.
Mokoala, Kgomotso M. G.
Moshokoa, Evelyn
Maes, Alex
Mokgoro, Neo P.
Van de Wiele, Christophe
Vorster, Maria
Sathekge, Mike M.
CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 392 - 401
[39] 68Ga-PSMA Uptake in an Incidentally Detected Gastrointestinal Stromal Tumor in a Case of Suspected Carcinoma Prostate
Sasikumar, Arun
Joy, Ajith
Pillai, M. R. A.
Bindu, S.
Sudin, S. R.
CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : E447 - E448
[40] Impact of 68Ga-PSMA PET/CT on Survival and Management in Prostate Cancer
Algin, Efnan
Okudan, Berna
Acikgoz, Yusuf
Sayan, Haluk
Bal, Oznur
Seven, Bedri
CURRENT MEDICAL IMAGING, 2024, 20

← 1 2 3 4 5 →